Q1 2026 results

KPN reports Q1 revenue growth of 0.6% with strong performance across consumer, SME, and wholesale segments. EBITDA rises 3.1% year-on-year.

Huhtamäki posts 1% comparable growth despite 5% reported revenue decline to €946.8M, hurt by €62.6M currency headwinds. Operating margin expands to 10.0%.

Coca-Cola stock surged 6.2% after beating Q1 earnings with 12% revenue growth to $12.47B and raising full-year guidance to 8-9%.

Telia Lietuva shareholders approved 2025 Annual Report with CSRD-compliant sustainability disclosure. Company also reported Q1 2026 interim results.

Telia Lietuva shareholders approved 2025 annual report featuring EU sustainability disclosure compliance and released Q1 2026 interim financial statements.

Gold Royalty posts record Q1 2026 results: $7.2M revenue, 1,920 GEOs, up 162% YoY. Maintains 7,500-9,300 GEO full-year guidance with growth from new acquisitions and mine ramp-ups.

Intel stock surged 23.6% after Q1 earnings crushed expectations, with data center revenue jumping 22% to $5.1B and adjusted net income soaring 156% to $1.5B.

Signify reports Q1 2026 results with stable margins and improved cash flow despite 5.1% sales decline, maintaining full-year guidance amid persistent market weakness.

SPIE reports Q1 revenue of €2.45 billion (+1.7% YoY) with -0.9% organic growth offset by €667M in acquisitions. Company reaffirms 2026 guidance.

Honeywell missed Q1 revenue targets at $9.1B versus $9.3B expected, though earnings beat estimates. Stock fell 3% amid aerospace spinoff concerns.

BioLife Solutions will report Q1 2026 earnings May 7, 2026, with management providing financial results and business updates via conference call.

Lee Enterprises reports 61% EBITDA growth, secures $50M investment, refinances debt from 9% to 5%. Earnings call set for May 7, 2026.

Wix announces Q1 2026 earnings release date and completes modified Dutch auction tender offer for share repurchase.

$ACTG will release Q1 2026 earnings May 7 before market open, with management conference call at 8:00 a.m. ET.

Orion posts strong Q1 with 17.8% revenue growth, 47.3% operating profit surge, and raises 2026 outlook. Pipeline advances boost investor confidence.

Finnish pharma $ORION reported 17.8% Q1 revenue growth to €417.7M, raised full-year guidance citing Nubeqa royalties and pipeline progress.

Pharming Group will report Q1 2026 results May 7 with conference call; 2026 Annual General Meeting scheduled for May 28.

$AT&T rose 0.39% on Q1 earnings beat, but wireless revenue weakness and flat per-user metrics raised sector concerns amid broader market gains.

Vertiv stock fell 2.5% despite beating Q1 earnings and raising full-year guidance, reflecting profit-taking after 351% annual gains rather than fundamental weakness.

Norsk Hydro schedules Q1 2026 earnings for April 29, 2026. Executives buy shares via LTIP and employee programs, signaling management confidence in company prospects.